Burshtyn D N, Barber B H
Department of Immunology, University of Toronto, Canada.
J Immunol. 1993 Sep 15;151(6):3070-81.
In an effort to examine the peptide binding properties of purified class I MHC molecules, we have developed a solid phase, radiolabeled peptide binding assay based on the use of H-2Db molecules bound to agarose beads via heavy chain-specific mAb. Using purified Db beta 2m, recovered from RMA-S cells and bound to immunoadsorbent beads through either alpha 1 or alpha 3 region specific antibodies, complete occupancy of these molecules could be achieved with 125I-Y366-374 influenza nucleoprotein peptide (Kd 10(-7) M). Approximately 12% of the Db beta 2m dimers recovered from RMA cells could be occupied by this influenza nucleoprotein peptide under the same conditions. When free Db heavy chains were isolated from beta 2m negative R1E.Db cells by bead-bound alpha 3-region specific antibody (28-14-8S) and were incubated with human beta 2m, high affinity (Kd 10(-8) M) binding sites were created for the 125I-Y367-374 influenza nucleoprotein peptide. In addition to demonstrating that a significant fraction of the heavy chains present in R1E.Db cells are in a beta 2m-reactive form, the R1E.Db cells provide an alternate approach to that of RMA-S derived Db beta 2m empties for the creation of homogeneous complexes of Db, beta 2m, and antigenic peptide. We anticipate that these bead-bound empty and defined peptide-class I complexes may be useful in the further study of class I MHC target structure formation and recognition.
为了研究纯化的I类主要组织相容性复合体(MHC)分子的肽结合特性,我们开发了一种基于使用通过重链特异性单克隆抗体与琼脂糖珠结合的H-2Db分子的固相放射性标记肽结合测定法。使用从RMA-S细胞中回收并通过α1或α3区域特异性抗体与免疫吸附珠结合的纯化Dbβ2微球蛋白,用125I-Y366-374流感核蛋白肽(解离常数10^(-7) M)可实现这些分子的完全占据。在相同条件下,从RMA细胞中回收的约12%的Dbβ2微球蛋白二聚体可被这种流感核蛋白肽占据。当通过珠结合的α3区域特异性抗体(28-14-8S)从β2微球蛋白阴性的R1E.Db细胞中分离游离的Db重链,并与人β2微球蛋白一起孵育时,为125I-Y367-374流感核蛋白肽创造了高亲和力(解离常数10^(-8) M)的结合位点。除了证明R1E.Db细胞中存在的相当一部分重链处于β2微球蛋白反应性形式外,R1E.Db细胞还提供了一种不同于从RMA-S衍生的Dbβ2微球蛋白空体的方法,用于创建Db、β2微球蛋白和抗原肽的同质复合物。我们预计这些珠结合的空体和确定的肽-I类复合物可能有助于进一步研究I类MHC靶标结构的形成和识别。